Profile
Spencer W.
Farr is the founder of Vista Therapeutics, Inc. where he holds the title of President.
Dr. Farr is also the founder of Xenometrix, Inc., Molecular Toxicology, Inc...
.
Dr. Farr is also the founder of Xenometrix, Inc., Molecular Toxicology, Inc...
Spencer W. Farr active positions
Companies | Position | Start |
---|---|---|
Vista Therapeutics, Inc.
Vista Therapeutics, Inc. BiotechnologyHealth Technology Vista Therapeutics, Inc. develops nanotechnology for multiplex biomarker measurement. Its NanoBioSensor technology provides continuous, real-time measurement of multiple biomarkers simultaneously in any clinical setting. The firm's technology can be used to improve the quality of animal data in drug development. The company was founded by Spencer W. Farr and Charles M. Lieber in 2007 and is headquartered in Santa Fe, NM. | Founder | 01/01/2007 |
Former positions of Spencer W. Farr
Companies | Position | End |
---|---|---|
Molecular Toxicology, Inc. | Chief Executive Officer | - |
Xenometrix, Inc.
Xenometrix, Inc. Medical SpecialtiesHealth Technology Xenometrix, Inc. operates as a biotechnology company with a proprietary gene profiling system that characterizes a cell's response when tested with compounds and other agents by the pattern of genes turned on and off in the cell. The company was founded by Spencer Farr and is headquartered in Boulder, CO. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Xenometrix, Inc.
Xenometrix, Inc. Medical SpecialtiesHealth Technology Xenometrix, Inc. operates as a biotechnology company with a proprietary gene profiling system that characterizes a cell's response when tested with compounds and other agents by the pattern of genes turned on and off in the cell. The company was founded by Spencer Farr and is headquartered in Boulder, CO. | Health Technology |
Vista Therapeutics, Inc.
Vista Therapeutics, Inc. BiotechnologyHealth Technology Vista Therapeutics, Inc. develops nanotechnology for multiplex biomarker measurement. Its NanoBioSensor technology provides continuous, real-time measurement of multiple biomarkers simultaneously in any clinical setting. The firm's technology can be used to improve the quality of animal data in drug development. The company was founded by Spencer W. Farr and Charles M. Lieber in 2007 and is headquartered in Santa Fe, NM. | Health Technology |
Molecular Toxicology, Inc. |
- Stock Market
- Insiders
- Spencer W. Farr